MedPath

Bacitracin Zinc and Polymyxin B Sulfate

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP (Sterile)

Approved
Approval ID

c6c69fa4-d7be-4c09-b7fa-53c40fad78a7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 16, 2012

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bacitracin Zinc and Polymyxin B Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-154
Application NumberANDA064046
Product Classification
M
Marketing Category
C73584
G
Generic Name
Bacitracin Zinc and Polymyxin B Sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateApril 1, 2008
FDA Product Classification

INGREDIENTS (4)

BACITRACIN ZINCActive
Quantity: 500 1 in 1 g
Code: 89Y4M234ES
Classification: ACTIB
POLYMYXIN B SULFATEActive
Quantity: 10000 1 in 1 g
Code: 19371312D4
Classification: ACTIB
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bacitracin Zinc and Polymyxin B Sulfate - FDA Drug Approval Details